Search
News
Earthquakes in Türkiye and Syria: infectious diseases expected to be a concern in two to four weeks
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
Scientific and technical publications
Expert opinion on rotavirus vaccination in infancy
ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.
Scientific and technical publications
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Scientific and technical publications
Expert opinion on rotavirus vaccination in infancy: public consultation opens
The final expert opinion on rotavirus vaccination in infancy aims to provide EU/EEA Member States with information to support the decision-making process on the possible introduction of rotavirus vaccination in infancy.
Topic page
Rotavirus infection
Rotavirus infection is an acute infectious disease mainly affecting children. The main symptoms are fever, vomiting and diarrhoea and many affected children suffer from extensive fluid loss in need of medical attention. The incubation period is 1-2 days.
Disease factsheet about rotavirus
Rotaviruses are the single most important cause of severe diarrhoeal illness in infants and young children worldwide. By the age of five years most children irrespective of socioeconomic setting will have been infected at least once. While infected, many children will be in need of medical attention due to extensive fluid loss.
Prevention and control measures for rotavirus
Two rotavirus vaccines were authorised for prevention of rotavirus gastroenteritis in 2006. Authorised vaccines provide a high level of protection against severe disease in need of medical attention. Evidence suggests that rotavirus vaccination should be initiated before 12 weeks of age and can be administered together with other infant vaccines.
Scientific and technical publications
Effectiveness of rotavirus vaccination: Generic study protocols for retrospective case control and cohort studies based on computerised databases
In Europe, routine rotavirus vaccination of infants at the national level has been introduced with one or two vaccine brands in Finland, Austria, Luxembourg and Belgium within well-baby clinics or administered by general practitioners and paediatricians. When introducing a new vaccine, it is crucial to conduct studies evaluating the vaccination’s impact and effectiveness in order to decide on recommendations for its future use.
Scientific and technical publications
Impact of rotavirus vaccination
When introducing a new vaccine, it is crucial to conduct studies evaluating the vaccination’s impact and effectiveness in order to decide on recommendations for its future use. To this end, ECDC has produced three generic protocols.
Tools for public health
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups.
- Diphtheria
- Europe
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection (HPV)
- Immunisation
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Measles
- Meningococcal disease
- Pertussis
- Pneumococcal disease
- Poliomyelitis
- Prevention and control
- Rotavirus infection
- Rubella
- Tetanus
- Tick-borne diseases
- Tuberculosis (TB)
- Varicella